Skip to main content
Fig. 3 | BMC Musculoskeletal Disorders

Fig. 3

From: Identification and characterization of human nucleus pulposus cell specific serotypes of adeno-associated virus for gene therapeutic approaches of intervertebral disc disorders

Fig. 3

NP cell viabilities after transduction with scAAV2, scAAV3 and scAAV6. A viral dose of 5000 vg/c was used to transduce 1 x 105 NP cells with scAAV2, scAAV3 and scAAV6. After transduction MTT assays were done on day 8, 16, 24, 32 and 48 of post-transduction to quantify the number of viable cells. Data represent the mean number of viable cells with standard deviation (SD) of three independent experiments, each performed in duplicat (p < 0.005). Error bars indicate SD values

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us